“food-and-drug-administration” Archives

in
Entry Author Date Location
UW Health Surgeon’s Startup Expanding Software to Monitor Patients 05/27/16 Wisconsin
Arrivo BioVentures Lands $49M to Fuel Hunt for New Drugs 05/26/16 Raleigh Durham
Magnomics Mastitis Diagnostic Lands Prize, Finds Potential NC Partner 05/23/16 Raleigh Durham
TransEnterix Shifts Surgical Robot Focus After FDA Rejection 05/11/16 Raleigh Durham
Argos Lays Off 18 and Executive Resigns, But Phase 3 Still on Track 04/20/16 Raleigh Durham
EnsoData Raises $550K to Develop Software That Analyzes Sleep Data 04/13/16 Wisconsin
Elanco Gets FDA Nod on Biological Drug for Dairy Cows 04/12/16 Indiana
Viamet Revisits IPO Plans, This Time With More Data 04/11/16 Raleigh Durham
Novo Nordisk, TransLoc, Duke Energy, & More NC Innovation News 04/04/16 Raleigh Durham
Heat Biologics Prices $6.8M Stock Sale to Continue Cancer Trials 03/18/16 Raleigh Durham
Argos Nabs Up to $60M to Continue Kidney Cancer Treatment Work 03/07/16 Raleigh Durham
Precision BioSciences, Chimerix, Spreedly, & More NC Innovation News 02/29/16 Raleigh Durham
NephroGenex Pauses Kidney Drug Trial to Restructure, Seek Merger 02/24/16 Raleigh Durham
After Failed Trial, Chimerix Shuts Down Two More Phase 3 Tests 02/22/16 Raleigh Durham
Syngenta, NC Biotech, PSEG Solar, & More NC Innovation News 02/08/16 Raleigh Durham
FDA Puts Heat Biologics Bladder Cancer Trial on Partial Hold 02/03/16 Raleigh Durham
Heat Biologics Seeks More Cash for Bladder Cancer Immunotherapy Push 01/22/16 Raleigh Durham
$100M Richer, Cempra Still Needs FDA OK To Market Pneumonia Drug 01/07/16 Raleigh Durham
Chimerix Stock Plunges After Anti-Infection Drug Fails Phase 3 Trial 12/28/15 Raleigh Durham
Neosensory Translates Sounds Into Vibrations to Aid Hearing-Impaired 12/14/15 Texas
Pozen, Tribute Pharma Nix Ireland Move in Favor of Canada HQ 12/08/15 Raleigh Durham
Bioventus Fleshes Out Bone-Healing Portfolio with BioStructures Deal 12/01/15 Raleigh Durham
Salvaged From Bankruptcy, TranS1 Medical Device Finds New Life 11/17/15 Raleigh Durham
Bristol-Myers to Add Cardioxyl’s Heart Failure Drug With $300M Deal 11/02/15 Raleigh Durham
Humacyte Lands $150M Series B for Phase 3 Study of Lab-Grown Veins 10/20/15 Raleigh Durham
Cempra Antibiotic Hits Phase 3 Target, FDA Filing Planned 10/16/15 Raleigh Durham
AtriCure to Buy Heart Device Developer nContact for $99M 10/05/15 Raleigh Durham
TransEnterix Acquires SOFAR Surgical Robotics Unit in $100M Deal 09/21/15 Raleigh Durham
Raleigh-Durham Roundup: Biotech Center, AvidExchange, Cempra, & More 09/21/15 Raleigh Durham
Alzheimer’s Drug Firm vTv Therapeutics Sets Terms for $125M IPO 07/20/15 Raleigh Durham
Page 1 of 3 next page »